Tower Research Capital (TRC)’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $46.5K | Sell |
620
-152
| -20% | -$12.5K | ﹤0.01% | 2798 |
|
|
2025
Q4 | $60.3K | Buy |
772
+390
| +102% | +$31.6K | ﹤0.01% | 2286 |
|
|
2025
Q3 | $32.5K | Sell |
382
-1,364
| -78% | -$109K | ﹤0.01% | 2875 |
|
|
2025
Q2 | $137K | Buy |
1,746
+1,380
| +377% | +$102K | ﹤0.01% | 2125 |
|
|
2025
Q1 | $26.5K | Sell |
366
-4,018
| -92% | -$337K | ﹤0.01% | 2710 |
|
|
2024
Q4 | $389K | Buy |
4,384
+1,630
| +59% | +$145K | 0.01% | 1236 |
|
|
2024
Q3 | $233K | Sell |
2,754
-702
| -20% | -$62.3K | 0.01% | 1481 |
|
|
2024
Q2 | $319K | Buy |
3,456
+2,325
| +206% | +$235K | 0.01% | 1718 |
|
|
2024
Q1 | $128K | Sell |
1,131
-3,320
| -75% | -$331K | ﹤0.01% | 1697 |
|
|
2023
Q4 | $415K | Buy |
4,451
+2,041
| +85% | +$180K | 0.01% | 1526 |
|
|
2023
Q3 | $221K | Buy |
2,410
+2,243
| +1,343% | +$241K | 0.01% | 1366 |
|
|
2023
Q2 | $20.3K | Sell |
167
-1,433
| -90% | -$155K | ﹤0.01% | 3373 |
|
|
2023
Q1 | $157K | Buy |
1,600
+1,401
| +704% | +$134K | 0.01% | 1512 |
|
|
2022
Q4 | $16K | Sell |
199
-1,417
| -88% | -$119K | ﹤0.01% | 3379 |
|
|
2022
Q3 | $123K | Buy |
1,616
+805
| +99% | +$77.4K | ﹤0.01% | 2384 |
|
|
2022
Q2 | $88K | Buy |
811
+653
| +413% | +$69.3K | ﹤0.01% | 2395 |
|
|
2022
Q1 | $16K | Sell |
158
-152
| -49% | -$14.5K | ﹤0.01% | 3771 |
|
|
2021
Q4 | $29K | Sell |
310
-1,524
| -83% | -$153K | ﹤0.01% | 3273 |
|
|
2021
Q3 | $203K | Buy |
1,834
+1,048
| +133% | +$119K | 0.01% | 1811 |
|
|
2021
Q2 | $91K | Sell |
786
-715
| -48% | -$82.2K | ﹤0.01% | 2511 |
|
|
2021
Q1 | $156K | Sell |
1,501
-767
| -34% | -$95.4K | ﹤0.01% | 2216 |
|
|
2020
Q4 | $273K | Sell |
2,268
-10,325
| -82% | -$1.04M | 0.01% | 1464 |
|
|
2020
Q3 | $1.09M | Buy |
12,593
+10,278
| +444% | +$884K | 0.01% | 907 |
|
|
2020
Q2 | $188K | Buy |
+2,315
| New | +$169K | 0.01% | 1841 |
|
|
2019
Q4 | – | Sell |
-502
| Closed | -$66K | – | 4408 |
|
|
2019
Q3 | $66K | Sell |
502
-238
| -32% | -$31K | ﹤0.01% | 1603 |
|
|
2019
Q2 | $91K | Buy |
+740
| New | +$85K | 0.01% | 1224 |
|
|
2018
Q2 | – | Sell |
-1,321
| Closed | -$107K | – | 4080 |
|
|
2018
Q1 | $107K | Buy |
+1,321
| New | +$102K | 0.01% | 1210 |
|
|
2017
Q4 | – | Sell |
-1,981
| Closed | -$121K | – | 4049 |
|
|
2017
Q3 | $121K | Buy |
1,981
+1,381
| +230% | +$84.1K | 0.01% | 1178 |
|
|
2017
Q2 | $36K | Buy |
+600
| New | +$38.3K | ﹤0.01% | 918 |
|
|
2017
Q1 | – | Sell |
-317
| Closed | -$22K | – | 3950 |
|
|
2016
Q4 | $22K | Buy |
+317
| New | +$20.2K | ﹤0.01% | 2054 |
|
|
2016
Q3 | – | Sell |
-100
| Closed | -$6K | – | 4478 |
|
|
2016
Q2 | $6K | Sell |
100
-545
| -84% | -$29.9K | ﹤0.01% | 3298 |
|
|
2016
Q1 | $32K | Buy |
645
+595
| +1,190% | +$29.6K | ﹤0.01% | 1027 |
|
|
2015
Q4 | $3K | Buy |
+50
| New | +$2.5K | ﹤0.01% | 3523 |
|
|
2015
Q3 | – | Sell |
-252
| Closed | -$14K | – | 4802 |
|
|
2015
Q2 | $14K | Buy |
252
+168
| +200% | +$8.32K | ﹤0.01% | 2416 |
|
|
2015
Q1 | $4K | Sell |
84
-316
| -79% | -$13.4K | ﹤0.01% | 3435 |
|
|
2014
Q4 | $17K | Sell |
400
-100
| -20% | -$3.94K | ﹤0.01% | 1723 |
|
|
2014
Q3 | $18K | Buy |
+500
| New | +$17.7K | ﹤0.01% | 2396 |
|
|
2014
Q2 | – | Sell |
-1,714
| Closed | -$60K | – | 4664 |
|
|
2014
Q1 | $60K | Buy |
1,714
+1,564
| +1,043% | +$51.9K | 0.01% | 966 |
|
|
2013
Q4 | $5K | Sell |
150
-2,726
| -95% | -$89.2K | ﹤0.01% | 3542 |
|
|
2013
Q3 | $90K | Buy |
2,876
+2,167
| +306% | +$64K | 0.01% | 1391 |
|
|
2013
Q2 | $20K | Buy |
+709
| New | +$18.7K | ﹤0.01% | 1727 |
|
Other funds holding USPH
BG
CCM
VCM
SAM
Tower Research Capital (TRC)'s USPH Position: Q1 2026 in Review
Tower Research Capital (TRC) reduced its US Physical Therapy (USPH) stake by 20% in Q1 2026, selling an estimated $12.5K and leaving 620 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.
Tower Research Capital (TRC) first reported a position in USPH in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.09M in Q3 2020. 229 funds tracked by Wall St. Rank hold USPH as of Q1 2026.
- Tower Research Capital (TRC) held 620 shares of US Physical Therapy worth $46.5K as of Q1 2026.
- Tower Research Capital (TRC) sold 152 US Physical Therapy shares in Q1 2026, an estimated $12.5K.
- US Physical Therapy made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2798 holding.
- Tower Research Capital (TRC) first reported a position in US Physical Therapy in Q2 2013 and has held it in 41 quarters since.
- Tower Research Capital (TRC)'s US Physical Therapy position peaked at $1.09M in Q3 2020.
- 229 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.